Genitourinary Cancer and Prosca Bladdr 2020

View overview page

The Genitourinary Cancer Channel on VJOncology is supported by a grant from Pfizer Inc and Merck KGaA.

The supporters have no influence over the production of the content.

If you are interested in becoming a supporter of The Genitourinary Cancer Channel, please contact us

Immunotherapy in prostate cancer

Emmanuel Seront • 7 Oct 2020

Unmet needs in mHSPC

Ursula Vogl • 7 Oct 2020

Genomic testing in prostate cancer

Emmanuel Seront • 7 Oct 2020

Second-line treatment of mHSPC

Ursula Vogl • 7 Oct 2020

Unmet need in bladder cancer

Arlene Siefker-Radtke • 14 Oct 2020

Advances in non-metastatic castration-resistant prostate cancer

Emmanuel Seront • 14 Oct 2020

Optimising treatment for advanced urothelial cancer: combination, maintenance or sequencing?

Arlene Siefker-Radtke • 14 Oct 2020

Challenges and treatment advances in mHSPC

Ursula Vogl • 14 Oct 2020

Improving precision of high-quality prostate cancer MRI

Anwar Padhani • 14 Oct 2020

PSMA-PET for patients with high-risk for de novo N1 disease

Jeremie Calais • 9 Oct 2020

NMIBC: new approaches

Amir Mostafid • 9 Oct 2020

Future of imaging and theranostics in prostate cancer

Jeremie Calais • 9 Oct 2020

NMIBC: relevance of prognostic markers

Amir Mostafid • 9 Oct 2020